Euronext announces quarterly review results of the BEL 20®, BEL Mid® and BEL Small®

Euronext announces quarterly review results for the AEX, AMX, AScX

Euronext Announces Volumes for August 2016

Euronext enters into a definitive agreement for the acquisition of a 20% stake in EuroCCP

Euronext Announces Volumes for July 2016

Euronext Publishes Second Quarter 2016 Results

Euronext Pursues Innovation Strategy with Tredzone

First Trading Day Ahold Delhaize on Euronext

La Biotech Pharnext s’introduit sur Alternext pour s’avancer dans le traitement de l’alzheimer

GenSight Biologics s’introduit sur Euronext : la première société de thérapie génique cotée en Europe